Pier Luigi Lollini

Professor

University of Bologna

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (7)

DAVIDE MARIA DONATI

Istituto Ortopedico Rizzoli

ITALY

View details

Maxim V. C. Greenberg

Université Paris Cité

FRANCE

View details

Laura Pazzaglia

IRCCS Istituto Ortopedico Rizzoli

ITALY

View details

EVELIN PELLEGRINI

IRCCS Istituto Ortopedico Rizzoli

ITALY

View details

Cristian Bassi

University of Ferrara

ITALY

View details

Patrizia Nanni

Associate Professor

University of Bologna

ITALY

View details

Pascale GILARDI-HEBENSTREIT

CNRS Délégation Paris B

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pier Luigi Lollini

Research Interests

Explore related searches

Contact this professor

Articles (12)

Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages

IL-1 Family Members in Bone Sarcomas

Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy

Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma

Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research

Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS–FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity

Prevention and Therapy of Metastatic HER-2<sup>+</sup> Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine

Divergent transcriptional and transforming properties of PAX3-FOXO1 and PAX7-FOXO1 paralogs

HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy

IFN-γ and CD38 in Hyperprogressive Cancer Development

Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma

The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?

Collaborators (7)

DAVIDE MARIA DONATI

Maxim V. C. Greenberg

Laura Pazzaglia

EVELIN PELLEGRINI

Cristian Bassi

Patrizia Nanni

Pascale GILARDI-HEBENSTREIT

Make your next move.